Figure 9
From: The ryanodine receptor mutational characteristics and its indication for cancer prognosis
Kaplan–Meier survival analysis based on RYR3 mutational status (mutant or WT). The data for overall survival (OS) time is shown for each subgroup. (A) The survival analysis based on RYR3 mutational status for all types of cancers. (B–G) The survival analysis based on RYR3 mutational status for each type of cancer, as indicated. Only cancer types with P ≤ 0.1 are shown. P values are indicated in each panel. The unit for time is days.
